There’s real reason for hope if you or someone you love has been touched by pancreatic cancer. This week the FDA approved a new pill, daraxonrasib, that in trials nearly doubled how long patients lived compared to standard chemotherapy — a median of about 13 months instead of under seven. Pancreatic cancer has been one of the toughest diagnoses out there for decades, the kind of news that makes a whole family go quiet in a waiting room. This doesn’t fix that overnight, and at close to $40,000 a month, plenty of families will be fighting an insurance battle right alongside the medical one. But scientists are calling it the first real crack in a wall that’s stood for a long time, and that’s worth holding onto.
Closer to home, in our wallets: the economy grew a modest 1.5% last quarter, a little slower than the start of the year, while prices are still climbing faster than most of us would like. It’s the kind of number that doesn’t make headlines the way a crisis would, but it’s the quiet math behind why grocery runs and gas fill-ups still feel tighter than they should. Worth keeping an eye on, especially with the Fed weighing what to do next about interest rates.
And then there’s Social Security. Congress has about six years before the trust fund runs low, and if nothing changes, benefits would shrink by a bit more than a fifth — not disappear, but shrink. A recent poll found a lot of us don’t actually know that distinction; more than a third of people thought benefits would stop altogether. It’s easy to tune this one out because the deadline feels far off and the fixes all sound painful. But this is the kind of thing where a little more attention now, from all of us, buys a lot more say later in how it gets solved. If you’ve got a parent or grandparent counting on that check, it’s worth a conversation before it becomes an emergency.
On a lighter note: a house in San Francisco covered top to bottom in painted faces of Latin rock legends just got officially protected as a city landmark. It’s been a neighborhood fixture for years, a little burst of color and memory in a part of the city that’s changed enormously. Stories like that remind us that the things worth protecting aren’t always monuments — sometimes they’re just a house that refused to stop telling a story.
It’s been a week of big medical hope, small economic worry, and a long-term problem that deserves more of our attention than it’s getting. That’s most weeks, honestly. We keep showing up for each other anyway, and that’s still the thing that gets us through.